Male birth control, like death, is always just around the corner. In 2014, the hope was that Vasalgel, a non-hormonal polymer gel that can be injected into the vas deferens, would hit the market by 2017. But the Parsemus Foundation, the non-profit organization funding Vasalgel, has since revised that projection to 2018, pending successful human trials and “public support.”
How Silicon Valley Will Replace Condoms
